Cargando…
Towards Cell free Therapy of Premature Ovarian Insufficiency: Human Bone Marrow Mesenchymal Stem Cells Secretome Enhances Angiogenesis in Human Ovarian Microvascular Endothelial Cells
Primary Ovarian Insufficiency (POI) refers to an ovarian loss of function in women under the age of 40. Unfortunately, currently, there is no effective treatment available for POI-related infertility. Alternatives such as the use of egg donations are culturally and ethically unacceptable to many cou...
Autores principales: | Park, Hang-Soo, Ashour, Dalia, Elsharoud, Amro, Chugh, Rishi Man, Ismail, Nahed, EL Andaloussi, Abdeljabar, Al-Hendy, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269190/ https://www.ncbi.nlm.nih.gov/pubmed/32494757 http://dx.doi.org/10.24966/srdt-2060/100019 |
Ejemplares similares
-
Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model
por: Park, Hang-soo, et al.
Publicado: (2021) -
Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model
por: Park, Hang-Soo, et al.
Publicado: (2021) -
The Role of Gene Therapy in Premature Ovarian Insufficiency Management
por: Atabiekov, Ihor, et al.
Publicado: (2018) -
Umbilical Cord Blood Mesenchymal Stem Cells as an Infertility Treatment for Chemotherapy Induced Premature Ovarian Insufficiency
por: Mohamed, Sara A., et al.
Publicado: (2019) -
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature
por: Igboeli, Prosper, et al.
Publicado: (2020)